Multi-institutional report on toxicities from combined radiation and nivolumab.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.5_suppl.39
Abstract: 39Background: Indications for Nivolumab (NIVO), a checkpoint inhibitor immunotherapy drug, in treating a variety of metastatic malignancies has markedly increased. Radiation therapy (RT) is also commonly used in this patient population, however, there are limited… read more here.
Keywords: institutional report; combined radiation; multi institutional; report toxicities ... See more keywords